Picture of 4d Pharma logo

DDDD — 4d Pharma Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-48.42%
3m-66.61%
6m-69.93%
1yr-84.32%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-84.66%
50d MA-51.01%
200d MA-65.55%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-185.24%
Return on Equity-210.91%
Operating Margin-13502.49%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for DDDD

4d Pharma share price hits a one-year high background image

4d Pharma share price hits a one-year high

Shares in 4d Pharma (LON:DDDD) are currently trading close to a 52 week high, with the share price up by around 24.1% to 144 over the past week. On a one-month basis, the 4d Pharma price has risen by 58.2%. For investors holding the st...

Breakout Alert: 3 month price surge for 4d Pharma background image

Breakout Alert: 3 month price surge for 4d Pharma

Shares in 4d Pharma (LON:DDDD) have led a strong move away from the market average in recent weeks. On a relative price strength basis, the price is up by 98.8% against the market over the past three months. The last close price was 98...

Shares in 4d Pharma outperform over three months background image

Shares in 4d Pharma outperform over three months

Shares in 4d Pharma (LON:DDDD) have outperformed the market over the past three months, signalling optimism on the part of investors at a time of economic uncertainty. Based on relative price strength against the market, the company's...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of 4d Pharma EPS forecast chart

Profile Summary

4D pharma plc is a United Kingdom-based pharmaceutical company. The Company is focused on developing Live Biotherapeutic Products (LBPs), a class of drugs derived from the human gut microbiome. The Company's LBPs are biologics based on live organisms, namely single strains of bacteria. It has developed MicroRx, its LBP discovery platform. MicroRx interrogates its library of bacterial isolates for therapeutic functionality and characterizes the bacterial isolates using a range of complementary tools and technologies. Its microbiome profiling platform, MicroDx, analyses the microbiome to aid the diagnosis and treatment of patients with its Live Biotherapeutics. Its MicroRx platform has generated a pipeline of development programs in therapeutic areas, including immuno-oncology, gastrointestinal (GI), respiratory, autoimmune and central nervous system (CNS) diseases. Its MicroRx enables the discovery of MRx-4DP0004, which is engaged in an ongoing Phase I/II with partly controlled asthma.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
January 10th, 2014
Public Since
February 18th, 2014
No. of Employees
95
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
180,337,577

DDDD Share Price Performance

Latest News for DDDD

Upcoming Events for DDDD

Half Year 2022 4D Pharma PLC Earnings Release

Similar to DDDD

Picture of 4Basebio logo

4Basebio

gb flag iconLondon Stock Exchange

Picture of Allergy Therapeutics logo

Allergy Therapeutics

gb flag iconLondon Stock Exchange

Picture of Arecor Therapeutics logo

Arecor Therapeutics

gb flag iconLondon Stock Exchange

Picture of Avacta logo

Avacta

gb flag iconLondon Stock Exchange

Picture of Bioventix logo

Bioventix

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email